SCHEMBL9494775

SCHEMBL9494775

CCc1cc(NCc2ccc(-c3ccccc3-c3nnn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)cc2)c(I)c(CC)n1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 12/20 0.65
AGTR2 P50052 10/20 0.65
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
DRD4 P21917 1/20 0.36
OPRM1 P35372 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9494452 0.91 AGTR1 (0.65) AGTR1AGTR2PDE4APDE4BPDE4C
SCHEMBL9495741 0.90 AGTR1 (0.65) AGTR1AGTR2PDE4APDE4BPDE4C
SCHEMBL9499344 0.87 AGTR1 (0.47) AGTR1AGTR2PDE4APDE4BPDE4C
SCHEMBL9496626 0.83 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9454840 0.83 AGTR1 (0.64) AGTR1AGTR2
SCHEMBL9494926 0.82 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9494765 0.80 AGTR1 (0.40) AGTR1AGTR2CYP3A4CYP2D6CYP2C9
SCHEMBL9495030 0.80 AGTR1 (0.47) AGTR1AGTR2PDE4APDE4BPDE4C
SCHEMBL9499272 0.77 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9494669 0.76 AGTR1 (0.43) AGTR1AGTR2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236937-A Treating hypertension, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-17 US disclosed
EP-0499415-A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists ZENECA LIMITED (GB) 1992-08-19 EP disclosed